Literature DB >> 12609490

Complement-receptor-3 and scavenger-receptor-AI/II mediated myelin phagocytosis in microglia and macrophages.

Fanny Reichert1, Shlomo Rotshenker.   

Abstract

Microglia and macrophages express the alpha(M)/beta(2) integrin complement-receptor-3 (CR3/MAC-1; CD11b/CD18) and scavenger-receptor-AI/II (SRAI/II). Both can mediate myelin phagocytosis. We document that CR3/MAC-1 mediated myelin phagocytosis in microglia is modulated by complement and anti-CR3/MAC-1 mAbs. Complement augmented phagocytosis twofold. Anti-alpha(M) mAbs M1/70 and 5C6 inhibited and anti-beta(2) mAb M18/2 augmented myelin phagocytosis in the presence and absence of active complement. Active complement modulated phagocytosis inhibition by M1/70 and 5C6 and phagocytosis augmentation by M18/2. CR3/MAC-1 mediated myelin phagocytosis may thus be, at least partially, independent of but modulated by complement. Anti-beta(2) mAb Game-46 did not affect phagocytosis. However, combining M18/2 with Game-46 resulted in phagocytosis augmentation that was larger in magnitude than that induced by M18/2 alone. Thus, phagocytosis augmentation induced by one anti-beta(2) mAb was potentiated by another anti-beta(2) mAb. Combining M1/70 or 5C6 with M18/2 inhibited M18/2-induced augmentation. Overall, mAbs-induced phagocytosis modulation ranged three- to sevenfold from inhibition to augmentation. Anti-CR3/MAC-1 mAbs may reveal a mechanism by which native extracellular molecules bind to and modulate CR3/MAC-1 mediated myelin phagocytosis in microglia and macrophages. We further document SRAI/II mediated myelin phagocytosis in microglia and CR3/MAC-1 contributing to myelin phagocytosis two- to threefold more than SRAI/II when the two receptors function together.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12609490     DOI: 10.1016/s0969-9961(02)00008-6

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  36 in total

1.  Soluble complement receptor 1 protects the peripheral nerve from early axon loss after injury.

Authors:  Valeria Ramaglia; Ruud Wolterman; Maryla de Kok; Miriam Ann Vigar; Ineke Wagenaar-Bos; Rosalind Helen Mary King; Brian Paul Morgan; Frank Baas
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

Review 2.  The multifaceted profile of activated microglia.

Authors:  Marina A Lynch
Journal:  Mol Neurobiol       Date:  2009-07-23       Impact factor: 5.590

Review 3.  Myelin as an inflammatory mediator: Myelin interactions with complement, macrophages, and microglia in spinal cord injury.

Authors:  Timothy J Kopper; John C Gensel
Journal:  J Neurosci Res       Date:  2017-07-11       Impact factor: 4.164

Review 4.  The origin, fate, and contribution of macrophages to spinal cord injury pathology.

Authors:  Lindsay M Milich; Christine B Ryan; Jae K Lee
Journal:  Acta Neuropathol       Date:  2019-03-30       Impact factor: 17.088

Review 5.  Microglial Aβ receptors in Alzheimer's disease.

Authors:  Yang Yu; Richard D Ye
Journal:  Cell Mol Neurobiol       Date:  2014-08-23       Impact factor: 5.046

6.  Anti-inflammatory effects of ladostigil and its metabolites in aged rat brain and in microglial cells.

Authors:  Rony Panarsky; Lisandro Luques; Marta Weinstock
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-28       Impact factor: 4.147

7.  Differential expression of genes involved in the acute innate immune response to intracortical microelectrodes.

Authors:  Hillary W Bedell; Nicholas J Schaub; Jeffrey R Capadona; Evon S Ereifej
Journal:  Acta Biomater       Date:  2019-11-14       Impact factor: 8.947

8.  An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice.

Authors:  Marieta M Ruseva; Valeria Ramaglia; B Paul Morgan; Claire L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

Review 9.  Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease.

Authors:  Shlomo Rotshenker
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

10.  ATP and NO dually control migration of microglia to nerve lesions.

Authors:  Yuanli Duan; Christie L Sahley; Kenneth J Muller
Journal:  Dev Neurobiol       Date:  2009-01       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.